Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Baxter International (BAX) stock in plain English

Free brief · no signupStart here
BAXPublished Nov 17, 2026
Baxter International Inc
Healthcare · Medical Instruments & Supplies
Produces intravenous solutions, drug delivery devices, and kidney care equipment for hospitals and clinics worldwide.
Assets:
North Cove plantProduces a substantial share of domestic intravenous fluids from a single North Carolina site
Global manufacturing networkOperates approximately fifty production facilities across twenty countries
60,000 employeesMaintains a worldwide workforce supporting hospital clinical operations and device manufacturing
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

34
OPS ScoreOperating finances
Latest quote
-2.94%$25.39
$13.14B
n/a (loss)
$11.62B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 17, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was BAX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Baxter International (BAX) do?

Baxter International Inc (BAX) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Produces intravenous solutions, drug delivery devices, and kidney care equipment for hospitals and clinics worldwide. Baxter produces essential intravenous fluids, drug delivery pumps, and surgical tools distributed directly to global. It is worth $13.14B on the market and sold $11.62B over the last year.

Market cap
$13.14B
P/E ratio
None (reported a loss)
Annual sales
$11.62B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 17, 2026

Brands and businesses behind BAX

  • Hillrom: Sells smart hospital beds, patient handling devices, and operating room workflow systems to healthcare providers.
  • Welch Allyn: Manufactures physical exam instruments and vital sign diagnostic equipment sold to outpatient clinics and emergency rooms.
  • Novum IQ: Provides connected large volume and syringe infusion pumps to administer intravenous medications in hospitals.
  • Floseal: Produces a gelatin-based hemostatic matrix applied by surgeons to control active bleeding during operations.
  • Tisseel: Supplies fibrin sealant products used by surgical teams to control bleeding and glue tissue in operating suites.

BAX’s flags, in plain English

Each flag is a number from Baxter International’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.

Cheap on Cash Flow

Priced at 11.6 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.

Stupid Cash

Can pay this year's bills 1.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Debt Is Driving

Heavy debt, 123% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.

2 more risk notes open with the free trial. Try it free for 7 days.

Questions about BAX

How big is Baxter International?

Baxter International’s market cap is $13.14B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $11.62B: what customers paid the company over the last year, before any costs.

What is BAX’s P/E ratio?

BAX has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with BAX?

A single facility in North Carolina supplies the majority of domestic intravenous solutions, making operational interruptions a major supply risk. That is one risk on Baxter International’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Baxter International’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BAX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card